Geode Capital Management, LLC Corvus Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 566,863 shares of CRVS stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
566,863
Previous 563,009
0.68%
Holding current value
$1.84 Million
Previous $2.97 Million
0.84%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CRVS
# of Institutions
103Shares Held
38.1MCall Options Held
2.75MPut Options Held
1.17M-
Orbimed Advisors LLC San Diego, CA6.94MShares$22.6 Million0.98% of portfolio
-
Samlyn Capital, LLC New York, NY6.67MShares$21.7 Million0.56% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$10.6 Million18.22% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.03MShares$9.85 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$8.71 Million0.23% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $151M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...